CECSi Cell Therapy
Bullous Keratopathy
Phase 1/Phase 1 equivalentActive
Key Facts
About Cellusion
Developing iPSC-derived corneal endothelial cell injection therapy to address the global shortage of donor corneas for transplants.
View full company profile